Dr Louise Robertson
Postdoctoral Research Fellow
School of Pharmacy and Biomedical Science
College of Health
Eligible to supervise Masters and PhD - email supervisor to discuss availability.
| Year | Citation |
|---|---|
| 2025 | Chey, Y. C. J., Gierus, L., Lushington, C., Arudkumar, J. C., B. Geiger, A., Staker, L. G., . . . Thomas, P. Q. (2025). Optimal SpCas9- and SaCas9-mediated gene editing by enhancing gRNA transcript levels through scaffold poly-T tract reduction. BMC Genomics, 26(1), 138-1-138-12. Scopus6 WoS5 Europe PMC5 |
| 2025 | McLain, A., Kowalczyk, A., Baran-Rachwalska, P., Sutera, F. M., Robertson, L. J., Nielsen, N. S., . . . Moore, T. (2025). TGFBI R124H mutant allele silencing in granular corneal dystrophy type 2 using topical siRNA delivery. Journal of Controlled Release, 382, 113681. |
| 2024 | Bunting, M. D., Godahewa, G. I., McPherson, N. O., Robertson, L. J., Gierus, L., Piltz, S. G., . . . Thomas, P. Q. (2024). Investigating the potential of X chromosome shredding for mouse genetic biocontrol.. Sci Rep, 14(1), 13466. Europe PMC1 |
| 2022 | Robertson, L. J., Price, R., Moore, J. S., Curry, G., Farnan, J., Black, A., . . . Moore, T. (2022). IgG antibody production and persistence to 6 months following SARS-CoV-2 vaccination: A Northern Ireland observational study. Vaccine, 40(18), 2535-2539. Scopus11 WoS9 Europe PMC10 |
| 2022 | Faustini, S., Shields, A., Banham, G., Wall, N., Al-Taei, S., Tanner, C., . . . Richter, A. (2022). Cross reactivity of spike glycoprotein induced antibody against Delta and Omicron variants before and after third SARS-CoV-2 vaccine dose in healthy and immunocompromised individuals. Journal of Infection, 84(4), 579-613. Scopus16 WoS13 Europe PMC21 |
| 2022 | Jing, M., Bond, R., Robertson, L. J., Moore, J., Kowalczyk, A., Price, R., . . . Moore, T. (2022). User experience of home-based AbC-19 SARS-CoV-2 antibody rapid lateral flow immunoassay test. Scientific Reports, 12(1), 1173. Scopus6 WoS7 Europe PMC4 |
| 2022 | Moore, J. S., Robertson, L. J., Price, R., Curry, G., Farnan, J., Black, A., . . . Moore, T. (2022). Evaluation of the performance of a lateral flow device for quantitative detection of anti-SARS-CoV-2 IgG. Clinical Immunology Communications, 2, 130-135. Scopus1 |
| 2021 | Robertson, L. J., Moore, J. S., Blighe, K., Ng, K. Y., Quinn, N., Jennings, F., . . . Moore, T. (2021). Evaluation of the IgG antibody response to SARS CoV-2 infection and performance of a lateral flow immunoassay: cross-sectional and longitudinal analysis over 11 months.. BMJ Open, 11(6), 10 pages. Scopus17 WoS16 Europe PMC15 |
| 2021 | Jing, M., Bond, R., Robertson, L. J., Moore, J., Kowalczyk, A., Price, R., . . . Moore, T. (2021). User experience analysis of AbC-19 Rapid Test via lateral flow immunoassays for self-administrated SARS-CoV-2 antibody testing. Scientific Reports, 11(1), 13 pages. Scopus17 WoS15 Europe PMC13 |
| 2020 | Dawson, R., Guil, A. N., Robertson, L., Piltz, S., Hughes, J., & Thomas, P. (2020). Functional screening of GATOR1 complex variants reveals a role for mTORC1 deregulation in FCD and focal epilepsy. Neurobiology of Disease, 134, 104640. Scopus40 WoS35 Europe PMC28 |
| 2020 | Christie, K. A., Robertson, L. J., Conway, C., Blighe, K., DeDionisio, L. A., Chao-Shern, C., . . . Moore, C. B. T. (2020). Mutation-Independent Allele-Specific Editing by CRISPR-Cas9, a Novel Approach to Treat Autosomal Dominant Disease. Molecular Therapy, 28(8), 1846-1857. Scopus21 WoS17 Europe PMC21 |
| 2019 | Robertson, L., Featherby, T., Howell, S., Hughes, J., & Thomas, P. (2019). Paroxysmal and cognitive phenotypes in Prrt2 mutant mice. Genes, Brain and Behavior, 18(5), e12566-1-e12566-8. Scopus6 WoS6 Europe PMC5 |
| 2018 | Robertson, L., Pederick, D., Piltz, S., White, M., Nieto, A., Ahladas, M., . . . Thomas, P. Q. (2018). Expanding the RNA-Guided Endonuclease Toolkit for Mouse Genome Editing.. The CRISPR journal, 1(6), 431-439. WoS5 Europe PMC4 |
| Year | Citation |
|---|---|
| 2024 | Chey, Y., Gierus, L., Lushington, C., Arudkumar, J., Geiger, A., Staker, L., . . . Adikusuma, F. (2024). Enhancing gRNA Transcript levels by Reducing the Scaffold Poly-T Tract for Optimal SpCas9- and SaCas9-mediated Gene Editing. DOI |
| Date | Role | Research Topic | Program | Degree Type | Student Load | Student Name |
|---|---|---|---|---|---|---|
| 2024 - 2024 | Co-Supervisor | Development of Strategies for Invasive Rodent Population Control Through Modification of Naturally-Occurring Meiotic Drive Systems | Doctor of Philosophy | Doctorate | Full Time | Mr Luke Gierus |
Connect With Me
External Profiles
